In a surprising move, U.S. health officials have canceled $500 million in mRNA vaccine research, citing studies that question their safety and effectiveness. Critics warn this decision undermines vital public health advancements made during the pandemic.
Overdose deaths in the U.S. fell by nearly 30,000 last year, marking a significant decline in the drug crisis. Experts are cautiously optimistic about the progress, attributing it to improved treatment access and changes in the drug supply.
